Latest Strategy News

Genetic Signatures announces the upcoming departure of CEO Allison Rossiter, initiating a leadership transition as the company intensifies its focus on US market expansion.

Westgold Resources is set to demerge its non-core Reedy and Comet gold projects into a new ASX-listed entity, Valiant Gold, aiming to unlock value and fast-track cash flow through a strategic ore purchase agreement.

Diatreme Resources has submitted the Draft Environmental Impact Statement for its Northern Silica Project, marking a significant step toward regulatory approval and highlighting its potential to boost regional economies and support global solar energy growth.

Mt Malcolm Mines has executed a binding agreement to acquire key components of a 500,000 tonnes per annum gold processing plant, positioning itself for future self-processing and toll-milling opportunities in the prolific Leonora gold region.

EV Resources is set to begin a fully funded maiden diamond drilling program at its high-grade Los Lirios antimony project in Mexico, aiming to define a maiden JORC resource by Q3 2026. This marks a pivotal step toward production readiness and a broader 2026 exploration campaign.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Great Southern Mining reports significant new high-grade gold intercepts at its Amy Clarke prospect, extending mineralisation over 4.7km and setting the stage for follow-up drilling in 2026.

Godolphin Resources has significantly upgraded its Lewis Ponds deposit, increasing total tonnage by 78% and gold content by 34%, setting the stage for an upcoming scoping study.

Symal Group has locked in a $300 million revolving debt facility with major Australian banks, enhancing its financial flexibility to support strategic growth and acquisitions.

Future Metals NL has completed strategic planning that enhances its flagship Panton PGM Project’s value, driven by a 35% rise in platinum group metal prices and expanded exploration programs. The company is also advancing infrastructure options and strengthening its management team to accelerate development.

Fortescue Ltd has announced a binding agreement to acquire the remaining 64% of Alta Copper, gaining full control of the Cañariaco Copper Project in Peru. The deal values Alta Copper at C$139 million and aligns with Fortescue’s expanding copper strategy.

Dimerix has successfully completed recruitment and dosing of 286 adult patients in its Phase 3 ACTION3 trial evaluating DMX-200 for focal segmental glomerulosclerosis (FSGS), advancing toward regulatory discussions with the FDA.